{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,31]],"date-time":"2026-05-31T05:00:48Z","timestamp":1780203648952,"version":"3.54.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","contraceptionjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.contraception.2025.111052","type":"journal-article","created":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T10:10:55Z","timestamp":1755252655000},"page":"111052","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Induced and spontaneous abortion outcomes among individuals with sickle cell disease"],"prefix":"10.1016","volume":"152","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-0794-6626","authenticated-orcid":false,"given":"Emma","family":"Braun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyler","family":"McVay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathanael","family":"Koelper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kandace","family":"Gollomp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea H.","family":"Roe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2025.111052_bib1","doi-asserted-by":"crossref","first-page":"S512","DOI":"10.1016\/j.amepre.2009.12.022","article-title":"Population estimates of sickle cell disease in the U.S.","volume":"38","author":"Hassell","year":"2010","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.contraception.2025.111052_bib2","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0140-6736(17)30193-9","article-title":"Sickle cell disease","volume":"390","author":"Ware","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2025.111052_bib3","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.15374","article-title":"Estimated life expectancy and income of patients with sickle cell disease compared with those without sickle cell disease","volume":"2","author":"Lubeck","year":"2019","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.contraception.2025.111052_bib4","doi-asserted-by":"crossref","first-page":"E328","DOI":"10.1002\/ajh.25643","article-title":"Third trimester and early postpartum period of pregnancy have the greatest risk for ACS in women with SCD","volume":"94","author":"Asare","year":"2019","journal-title":"Am J Hematol"},{"key":"10.1016\/j.contraception.2025.111052_bib5","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1002\/ajh.27045","article-title":"Pregnancy-related thromboembolism in women with sickle cell disease: an analysis of national medicaid data","volume":"98","author":"Agarwal","year":"2023","journal-title":"Am J Hematol"},{"key":"10.1016\/j.contraception.2025.111052_bib6","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/00006250-198602000-00012","article-title":"Pregnancy in sickle cell disease","volume":"67","author":"Powars","year":"1986","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2025.111052_bib7","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1182\/blood-2014-11-607317","article-title":"Adverse maternal and perinatal outcomes in pregnant women with sickle cell disease: systematic review and meta-analysis","volume":"125","author":"Oteng-Ntim","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.contraception.2025.111052_bib8","first-page":"513","article-title":"Contraceptive use and preferences among females with sickle cell disease","volume":"104","author":"Roe","year":"2021","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.111052_bib9","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0002-9378(80)90241-0","article-title":"Outcome of pregnancy in sickle cell anemia and sickle cell-hemoglobin c disease: an analysis of 181 pregnancies in 98 patients, and a review of the literature","volume":"138","author":"Milner","year":"1980","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2025.111052_bib10","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1097\/01.AOG.0000127433.23611.54","article-title":"Outcome of pregnancy in homozygous sickle cell disease","volume":"103","author":"Serjeant","year":"2004","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2025.111052_bib11","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/GRF.0b013e3181a2b0c2","article-title":"First trimester surgical abortion","volume":"52","author":"Tristan","year":"2009","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.contraception.2025.111052_bib12","doi-asserted-by":"crossref","DOI":"10.1186\/s12905-018-0645-6","article-title":"Complications related to induced abortion: a combined retrospective and longitudinal low-up study","volume":"18","author":"Carlsson","year":"2018","journal-title":"BMC Womens Health"},{"key":"10.1016\/j.contraception.2025.111052_bib13","doi-asserted-by":"crossref","first-page":"348.e1","DOI":"10.1016\/j.ajog.2019.10.002","article-title":"Healthcare costs for abortions performed in ambulatory surgery centers vs office-based settings","volume":"222","author":"Leslie","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2025.111052_bib14","series-title":"Policy Analysis","article-title":"Medication abortion accounted for 63% of all US abortions in 2023\u2014an increase from 53% in 2020","author":"Jones","year":"2024"},{"key":"10.1016\/j.contraception.2025.111052_bib15","first-page":"25","article-title":"Outcomes of procedures for abortions and early pregnancy loss among people with sickle cell disease: a single-center experience","volume":"117","author":"Wade","year":"2025","journal-title":"J Natl Med Assoc"},{"key":"10.1016\/j.contraception.2025.111052_bib16","doi-asserted-by":"crossref","first-page":"3676","DOI":"10.1182\/blood.V86.10.3676.bloodjournal86103676","article-title":"Surgery and anesthesia in sickle cell disease. Cooperative study of sickle cell diseases","volume":"86","author":"Koshy","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.contraception.2025.111052_bib17","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/0049475514552550","article-title":"Complications of ERCP for choledocholithiasis in a sickle cell cohort","volume":"45","author":"Cawich","year":"2015","journal-title":"Trop Doct"},{"key":"10.1016\/j.contraception.2025.111052_bib18","first-page":"1533","article-title":"Cholecystectomy in sickle cell anemia patients: perioperative outcome of 364 cases from The National preoperative transfusion study. Preoperative transfusion in sickle cell disease study group","volume":"89","author":"Haberkern","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.contraception.2025.111052_bib19","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1213\/ANE.0000000000006463","article-title":"Current evidence and rationale to guide perioperative management, including transfusion decisions, in patients with sickle cell disease","volume":"136","author":"Azbell","year":"2023","journal-title":"Anesth Analg"},{"key":"10.1016\/j.contraception.2025.111052_bib20","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/S0140-6736(12)61726-7","article-title":"The transfusion alternatives pre-operatively in sickle cell disease (TAPS) study: a randomised, controlled, multicentre clinical trial","volume":"381","author":"Howard","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2025.111052_bib21","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1182\/bloodadvances.2019001143","article-title":"American society of hematology 2020 guidelines for sickle cell disease: transfusion support","volume":"4","author":"Chou","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.contraception.2025.111052_bib22","doi-asserted-by":"crossref","first-page":"125.e1","DOI":"10.1016\/j.ajog.2008.04.016","article-title":"Morbidity associated with sickle cell disease in pregnancy","volume":"199","author":"Villers","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2025.111052_bib23","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/bjh.14655","article-title":"Increased incidence of VTE in sickle cell disease patients: risk factors, recurrence and impact on mortality","volume":"178","author":"Brunson","year":"2017","journal-title":"Br J Haematol"},{"key":"10.1016\/j.contraception.2025.111052_bib24","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1089\/jwh.2022.0046","article-title":"Sex as an independent risk factor for venous thromboembolism in sickle cell disease: a cross-sectional study","volume":"31","author":"Roe","year":"2022","journal-title":"J Womens Health"},{"key":"10.1016\/j.contraception.2025.111052_bib25","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1182\/bloodadvances.2018024802","article-title":"American society of hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy","volume":"2","author":"Bates","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.contraception.2025.111052_bib26","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.contraception.2021.03.016","article-title":"Society of family planning clinical recommendations: management of individuals with bleeding or thrombotic disorders undergoing abortion","volume":"104","author":"Lee","year":"2021","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.111052_bib27","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/SLA.0b013e3181b7fca6","article-title":"A validation study of a retrospective venous thromboembolism risk scoring method","volume":"251","author":"Bahl","year":"2010","journal-title":"Ann Surg"},{"issue":"1_","key":"10.1016\/j.contraception.2025.111052_bib28","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.amjsurg.2009.10.006","article-title":"Risk assessment as a guide for the prevention of the many faces of venous thromboembolism","volume":"199","author":"Caprini","year":"2010","journal-title":"Am J Surg"},{"key":"10.1016\/j.contraception.2025.111052_bib29","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.amjmed.2012.12.016","article-title":"Venous thromboembolism in adults with sickle cell disease: a serious and under-recognized complication","volume":"126","author":"Naik","year":"2013","journal-title":"Am J Med"},{"key":"10.1016\/j.contraception.2025.111052_bib30","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.contraception.2012.09.001","article-title":"First-trimester abortion in women with medical conditions: SFP guideline #20122","volume":"86","author":"Guiahi","year":"2012","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.111052_bib31","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/01.AOG.0000116260.81570.60","article-title":"Risk factors for legal induced abortion-related mortality in the United States","volume":"103","author":"Bartlett","year":"2004","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2025.111052_bib32","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1182\/hematology.2019000039","article-title":"Complications in pregnant women with sickle cell disease","volume":"2019","author":"Smith-Whitley","year":"2019","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.contraception.2025.111052_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.conx.2024.100105","article-title":"Experiences of delay-causing obstacles and mental health at the time of abortion seeking","volume":"6","author":"Wasser","year":"2024","journal-title":"Contracept X"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782425002434?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782425002434?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,31]],"date-time":"2026-05-31T04:24:55Z","timestamp":1780201495000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782425002434"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":33,"alternative-id":["S0010782425002434"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2025.111052","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Induced and spontaneous abortion outcomes among individuals with sickle cell disease","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2025.111052","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111052"}}